China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II Clinical Trial of Vinorelbine Versus Vinorelbine in Combination With Chidamide and Toripalimab in Advanced Triple-Negative Breast Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135645
Registration Time: 2026/10/31
Type: Interventional study
Primary Sponsor: First Medical Center, Chinese People's Liberation Army General Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349615
Published by HT Digital Content Services with permission from Health Daily Digest....